# Human Urine Sample Collection for Alport Nephropathy Biomarker Studies

> **NCT01602835** · — · TERMINATED · sponsor: **Novartis Pharmaceuticals** · enrollment: 80 (actual)

## Conditions studied

- Alport Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01602835
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-09
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2014-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01602835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01602835, "Human Urine Sample Collection for Alport Nephropathy Biomarker Studies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01602835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*